Westside Investment Management, Inc. Sage Therapeutics, Inc. Transaction History

Westside Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$16.75 - $48.98 $6,700 - $19,592	-400 Reduced 57.14%	300 $6.17 Million
Q1 2022 Apr 25, 2022	SELL	$30.71 - $45.71 $59,884 - $89,134	-1,950 Reduced 73.58%	700 $23,000
Q1 2021 Apr 14, 2021	SELL	$70.65 - $96.76 $5,298 - $7,257	-75 Reduced 2.75%	2,650 $198,000
Q4 2020 Jan 15, 2021	SELL	$58.41 - $89.06 $61,330 - $93,513	-1,050 Reduced 27.81%	2,725 $235,000
Q3 2020 Oct 14, 2020	SELL	$41.13 - $62.45 $20,565 - $31,225	-500 Reduced 11.7%	3,775 $230,000
Q2 2020 Jul 21, 2020	BUY	$25.95 - $43.15 $7,785 - $12,945	300 Added 7.55%	4,275 $177,000
Q1 2020 Apr 16, 2020	BUY	$26.15 - $77.24 $103,946 - $307,029	3,975 New	3,975 $114,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Westside Investment Management, Inc. with notifications on news.